Home
About
Pricing
Log In
Back
FFF

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

Forbidden Foods Limited

πŸ‡¦πŸ‡Ί ASX

πŸ” FOOD PRODUCTS

πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

2
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Forbidden Foods Ltd. operates as a premium food company. The company is headquartered in Box Hill, New South Wales. The company went IPO on 2020-08-31. The firm is engaged in the provision of goods to customers in the food and beverage industry, operating within retail, food service, food manufacturing and quick service restaurants. The company is specializing in the sourcing, development and sales of innovative, health focused food products globally. The firm creates healthy and nutritious products that engage, delight and inspire health-conscious consumers. The firm sells products through its brand, Blue Dinosaur. Blue Dinosaur is a healthy protein bar and plant-based snacking company. Blue Dinosaur products include peanut butter bars, snack bars, protein bars, bites, and energy bars. Its subsidiaries include Blue Dinosaur Pty Ltd, Forbidden Foods (Australia) Pty Ltd, Forbidden Foods (USA) Inc., and Forbidden Foods (US) LLC.

πŸ“ˆ Performance

Price History

-97.00%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.01

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in FFF

0

πŸ“Š Total Capital Earnings

$2K

πŸ”ƒ Average investment frequency

55 weeks

πŸ’΅ Average investment amount

$470

⏰ Last time a customer invested in FFF

531 days
FFF investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

πŸ™‹ Legal gender of investors

Female

Male

Pearlers who invest in FFF also invest in...

Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

18.72%

πŸ“Š Share price

$150.33 AUD

⛳️ DIVERSIFIED

πŸ€– TECHNOLOGY

🌏 GLOBAL

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 32,065 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

πŸ™Œ Performance (5Yr p.a)

-6.08%

πŸ“Š Share price

$199.24 AUD

πŸ•ŠοΈ SOCIALLY AWARE

🧬 BIOTECHNOLOGY

βš–οΈ HIGH GOVERNANCE

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

9.66%

πŸ“Š Share price

$110.37 AUD

πŸ‡¦πŸ‡Ί AUSTRALIA

🧱 MATERIALS

πŸ’Έ FINANCIALS

πŸ“ˆ HIGH PRICE GROWTH

⛳️ DIVERSIFIED

OMG Group Ltd. operates as a premium food company. The firm is specialized in delivering health-focused products through its two flagship brands, Blue Dinosaur and Oat Milk Goodness (OMG). Its Blue Dinosaur products include Protein Bars, Protein Balls, Protein Powder, Snack Bars, and Snack Bites.

πŸ™Œ Performance (5Yr p.a)

-19.29%

πŸ“Š Share price

$0.01 AUD

πŸ” FOOD PRODUCTS

Want more shares? Try these...

πŸ“Š Share price

$0.04 AUD